← Leaderboards
Hasem Habelhah
University Of Iowa
$4,539,596
Attributed
$4,539,596
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $583.9K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,539,596 · 5
By mechanism
R01$3,695,346 · 3
R21$844,250 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Sonia Ryang$198,414
- Mark K Reagan$900,375
- David W Peate$834,264
- Jason Rothman$20,682
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoApoptosisMediatingPathway InteractionsResponseExhibitsResistanceCancer CellCessation Of LifeCell SurvivalCell DeathUbiquitinationTraf2 GeneKnock-DownOverexpressionCell LineCancer Cell LineMalignant NeoplasmsCellsNeoplasm MetastasisAffectLightAntibodiesNovel Therapeutic Intervention
Grant awards (17)
The roles of TRAF2 and RIP1 in breast cancer cell survival$352,172
R01 · FY2025 · CA · contact PI
The roles of TRAF2 and RIP1 in breast cancer cell survival$334,564
R01 · FY2024 · CA · contact PI
The roles of TRAF2 and RIP1 in breast cancer cell survival$345,129
R01 · FY2023 · CA · contact PI
The roles of TRAF2 and RIP1 in breast cancer cell survival$352,172
R01 · FY2022 · CA · contact PI
Therapeutic efficacies of neutrophil elastase and RIP1 inhibitors in acute lung injury$231,750
R21 · FY2022 · AI · contact PI
Therapeutic efficacies of neutrophil elastase and RIP1 inhibitors in acute lung injury$193,125
R21 · FY2021 · AI · contact PI
HtrA2-mediated RIP1 cleavage regulates neuronal inflammation and death$190,625
R21 · FY2018 · NS · contact PI
HtrA2-mediated RIP1 cleavage regulates neuronal inflammation and death$228,750
R21 · FY2017 · NS · contact PI
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation$292,856
R01 · FY2014 · CA · contact PI
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation$283,799
R01 · FY2013 · CA · contact PI
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation$301,913
R01 · FY2012 · CA · contact PI
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation$301,913
R01 · FY2011 · CA · contact PI
RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB Activation$311,250
R01 · FY2010 · CA · contact PI
Regulation of TRAF2 Activity in Normal and Tumor Cells$203,376
R01 · FY2009 · CA · contact PI
Regulation of TRAF2 Activity in Normal and Tumor Cells$203,376
R01 · FY2008 · CA · contact PI
Regulation of TRAF2 Activity in Normal and Tumor Cells$203,376
R01 · FY2007 · CA · contact PI
Regulation of TRAF2 Activity in Normal and Tumor Cells$209,450
R01 · FY2006 · CA · contact PI